LAXAI Life Sciences built around the thesis that integrated programs move 20-30% faster on average, IP continuity and process knowledge don't survive vendor handoffs, and sponsor companies with fewer, deeper CDMO relationships consistently outperform.

LAXAI Life Sciences is a leading small molecule CRDMO providing end-to-end Integrated Drug Discovery, Development, and Manufacturing solutions to the pharmaceutical and biotech industries globally. With a focus on innovation, sustainability, and regulatory compliance, we leverage state-of-the-art infrastructure and a highly skilled scientific team to deliver efficient, scalable, and de-risked solutions. To date, we have successfully completed over 150 CMC projects and 20+ integrated discovery programs. We specialize in managing complex high-energy chemistries using safety-conscious methods and are committed to fostering sustainable indigenous supply chains and advancing green chemistry innovations. Our services span from target identification to clinical candidate selection, supporting clients with expertise in synthetic and medicinal chemistry, biology, DMPK, and toxicology. Additionally, we offer custom development, synthesis, and manufacturing of KSMs/RSMs and specialty chemicals for global companies. We excel in scaling complex synthetic processes, including stereoselective synthesis, nitration, bromination, deuteration, and advanced purification techniques. At LAXAI, we ensure seamless tech transfer from pilot to commercial scale, with flexible business models that accommodate diverse partnership needs—from fee-for-service to risk-sharing collaborations. We take pride in our 100% regulatory and EHS compliance, enabling clients to confidently achieve their drug development goals. Discover how LAXAI Life Sciences can accelerate your drug development journey with precision, safety, and innovation. For more information, write to us at bd@laxai.com or visit our website: www.laxai.com.

Founded 2007